Vol.

41

No.

38

October 16, 2015Oct 16, 2015

Free

DOWNLOAD THE PDF

Cover Story

Judge Nixes HRSA's Second Attempt To Enact Orphan Drug Discounts in 340B

By Matthew Bin Han Ong

A federal judge has ruled against the Health Resources and Services Administration over provider access to 340B Drug Pricing Program discounts for orphan drugs.

340B Guidance to Scale Back Discounts; Hospitals Will Need to Show Patient Benefit

By Matthew Bin Han Ong

NCCN Unveils Evidence Blocks As Part of Oncology Guidelines

Recent Issues

Judge Nixes HRSA's Second Attempt To Enact Orphan Drug Discounts in 340B

340B Guidance to Scale Back Discounts; Hospitals Will Need to Show Patient Benefit

NCCN Unveils Evidence Blocks As Part of Oncology Guidelines

In Brief

Hidalgo Named Director of BIDMC Clinical Cancer Programs

Alec Kimmelman named chair of radiation oncology at NYU Langone

Maciej Lesniak named chair of neurological surgery at Northwestern University

Ann Nattinger appointed senior associate dean for research at Medical College of Wisconsin

Edward Schaeffer joins Northwestern as chair of urology

Peter Kanetsky elected president of American Society of Preventive Oncology

IBM acquires Merge Healthcare Inc.

American College of Gastroenterology holds first annual SCOPY awards

Eli Lilly and Co. to expand its NYC research center

Funding Opportunities

SU2C Offering $7.5 Million for Early-Career Investigators

Drugs & Targets

FDA Approves Opdivo in Non-Squamous NSCLC

FDA Orphan Designation granted to Blueprint’s BLU-554

European Orphan Designations granted to CF102 and ENMD-2076

Genentech and Arvinas enter into license agreement

Ontario Institute for Cancer Research, Novera, and Janssen to collaborate on small molecule drugs for hematological cancers

Eli Lilly and Innovent expand their anti-PD-1 collaboration

Sequenom to collaborate with University Medical Center Hamburg-Eppendorf

MedImmune joins Human Vaccine Project

Recent Issues

Renew today!

Subscriber content